ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,949.28
-1.24%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Sangamo Therapeutics Inc (SGMO)

  7. Sangamo Therapeutics Inc (SGMO) 뉴스

SGMO Sangamo Therapeutics Inc

0.5101
0.0071 (1.41%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sangamo Therapeutics Inc SGMO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.0071 1.41% 0.5101 09:00:00
개장가 저가 고가 종가 전일 종가
0.52 0.503 0.5339 0.5178 0.503
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202405:35BWSangamo Therapeutics to Present Neurology-Focused..
22/03/202421:05BWSangamo Therapeutics Announces Pricing of $24.0 Million..
13/03/202421:05BWSangamo Therapeutics Reports Recent Business Highlights and..
13/03/202421:01BWSangamo Therapeutics Announces Data From Novel Proprietary..
13/03/202407:30BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
28/02/202407:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202407:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/02/202422:05BWSangamo Therapeutics Announces U.S. FDA Alignment on..
07/02/202406:35EDGAR2Form 8-K - Current report
06/02/202408:01BWSangamo Therapeutics Announces Updated Phase 1/2 STAAR Study..
27/01/202401:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/01/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202407:09EDGAR2Form 8-K - Current report
13/12/202321:55EDGAR2Form 8-K - Current report
29/11/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202306:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202305:02EDGAR2Form 8-K - Current report
02/11/202305:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202305:02EDGAR2Form 8-K - Current report
02/11/202305:01BWSangamo Therapeutics Announces Strategic Update and Reports..
26/10/202305:15BWSangamo Therapeutics Announces Third Quarter 2023 Conference..
24/10/202315:01BWSangamo Therapeutics to Present Pre-Clinical Data Showcasing..
21/09/202305:15BWSangamo Therapeutics to Present at the Jefferies Cell &..
30/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/08/202305:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:08EDGAR2Form 8-K - Current report
09/08/202305:01BWSangamo Therapeutics Reports Recent Business Highlights and..
02/08/202305:15BWSangamo Therapeutics Announces Second Quarter 2023..
20/07/202321:05BWSangamo Therapeutics and Chroma Medicine Announce Option and..
17/07/202321:05BWSangamo Therapeutics Announces Research Evaluation and..
29/06/202321:05BWSangamo Therapeutics and Voyager Therapeutics Enter License..

최근 히스토리

NASDAQ
SGMO
Sangamo Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유